Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A De Man

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
The British Journal of Surgery|September 1, 2017
Retrospective study on timing of resection of hepatocellular adenomaA J Klompenhouwer, M E E Bröker, M G J Thomeer, et al.
The Netherlands Journal of Medicine|October 1, 1990
Selection of asymptomatic HIV carriers for antiviral therapyR A de Man, S W Schalm, S Sprecher-Goldberger, et al.
Gut|June 1, 2005
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapyH J Flink, D Sprengers, B E Hansen, et al.
Journal of Viral Hepatitis|December 15, 2000
Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virusL M Wolters, A B van Nunen, P Honkoop, et al.
Journal of Viral Hepatitis|June 26, 2003
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infectionM van Zonneveld, A B van Nunen, H G M Niesters, et al.
The Netherlands Journal of Medicine|January 27, 2012
Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patientsC D M Witjes, J N M IJzermans, A A van der Eijk, et al.
Gastroenterology|October 10, 1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging studyF Nevens, J Main, P Honkoop, et al.
Journal of Viral Hepatitis|January 30, 2009
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeksJ G P Reijnders, W F Leemans, B E Hansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]A A van der Eijk, J K Doorduijn, H L A Janssen, et al.
The British Journal of Radiology|December 11, 2007
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinomaI C van den Bos, S M Hussain, R S Dwarkasing, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
The British Journal of Surgery|September 1, 2017
Retrospective study on timing of resection of hepatocellular adenomaA J Klompenhouwer, M E E Bröker, M G J Thomeer, et al.
The Netherlands Journal of Medicine|October 1, 1990
Selection of asymptomatic HIV carriers for antiviral therapyR A de Man, S W Schalm, S Sprecher-Goldberger, et al.
Gut|June 1, 2005
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapyH J Flink, D Sprengers, B E Hansen, et al.
Journal of Viral Hepatitis|December 15, 2000
Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virusL M Wolters, A B van Nunen, P Honkoop, et al.
Journal of Viral Hepatitis|June 26, 2003
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infectionM van Zonneveld, A B van Nunen, H G M Niesters, et al.
The Netherlands Journal of Medicine|January 27, 2012
Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patientsC D M Witjes, J N M IJzermans, A A van der Eijk, et al.
Gastroenterology|October 10, 1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging studyF Nevens, J Main, P Honkoop, et al.
Journal of Viral Hepatitis|January 30, 2009
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeksJ G P Reijnders, W F Leemans, B E Hansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]A A van der Eijk, J K Doorduijn, H L A Janssen, et al.
The British Journal of Radiology|December 11, 2007
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinomaI C van den Bos, S M Hussain, R S Dwarkasing, et al.
Pageof 17